Author:
Miteva Mariya,Nisheva-Pavlova Maria
Reference15 articles.
1. Hanif F, Muzaffar K, Perveen K, Malhi SM, Simjee ShU. Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment. Asian Pac J Cancer Prev. 2017 Jan 1;18(1):3-9. doi: 10.22034/APJCP.2017.18.1.3. PMID: 28239999; PMCID: PMC5563115.
2. Fernandes C, Costa A, Osório L, et al. Current Standards of Care in Glioblastoma Therapy. In: De Vleeschouwer S, editor. Glioblastoma [Internet]. Brisbane (AU): Codon Publications; 2017 Sep 27. Chapter 11. Available from: https://www.ncbi.nlm.nih.gov/books/NBK469987/ doi: 10.15586/codon.glioblastoma.2017.ch11
3. Saeed, Numan & Hardan, Shahad & Abutalip, Kudaibergen & Yaqub, Mohammad. (2022). Is it Possible to Predict MGMT Promoter Methylation from Brain Tumor MRI Scans using Deep Learning Models?.
4. Turner DP. Sampling Methods in Research Design. Headache. 2020 Jan;60(1):8-12. doi: 10.1111/head.13707. PMID: 31913516.
5. Bakas, S., Sako, C., Akbari, H. et al. The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics. Sci Data 9, 453 (2022). https://doi.org/10.1038/s41597-022-01560-7